Literature DB >> 26086188

Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Hélène Busser1, Mehdi Najar1, Gordana Raicevic1, Karlien Pieters1, Rafael Velez Pombo2, Pierre Philippart3, Nathalie Meuleman4, Dominique Bron4, Laurence Lagneaux1.   

Abstract

Preparations of mesenchymal stromal cells (MSCs) are generally obtained from unfractionated tissue cells, resulting in heterogeneous cell mixtures. Several markers were proposed to enrich these cells, but the majority of these markers are defined for bone marrow (BM). Moreover, the surface markers of freshly isolated MSCs also differ from those of cultured MSCs in addition to a phenotypic variation depending on the MSC source. For tissue engineering applications, it is crucial to start with a well-defined cell population. In this study, we performed immunomagnetic selections with five single surface markers to isolate MSC subpopulations from BM and adipose tissue (AT): CD271, SUSD2, MSCA-1, CD44, and CD34. We determined the phenotype, the clonogenicity, the proliferation, the differentiation capacity, and the immunoregulatory profile of the subpopulations obtained in comparison with unselected cells. We showed that native BM-MSCs can be enriched from the positive fractions of MSCA-1, SUSD2, and CD271 selections. In contrast, we observed that SUSD2 and MSCA-1 were unable to identify MSCs from AT, meaning they are not expressed in situ. Only the CD34(+) selection successfully isolated MSCs from AT. Interestingly, we observed that CD271 selection can define AT cell subsets with particular abilities, but only in lipoaspiration samples and not in abdominoplasty samples. Importantly, we found a population of clear CD34(+) fresh BM-MSCs displaying different properties. A single marker-based selection for MSC enrichment should be more advantageous for cell therapy and would enable the standardization of efficient and safe therapeutic intervention through the use of a well-identified and homogeneous cell population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26086188     DOI: 10.1089/scd.2015.0172

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  48 in total

1.  Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton's Jelly.

Authors:  Irena Walecka; Paulina Gil-Kulik; Arkadiusz Krzyżanowski; Marcin Czop; Dariusz Galkowski; Jolanta Karwat; Piotr Chomik; Małgorzata Świstowska; Anna Kwaśniewska; Anna Bogucka-Kocka; Janusz Kocki
Journal:  Med Sci Monit       Date:  2017-04-19

Review 2.  Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy.

Authors:  Saeedeh Darzi; Jerome A Werkmeister; James A Deane; Caroline E Gargett
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 3.  The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies.

Authors:  Francesco De Francesco; Maurizio Romano; Laura Zarantonello; Cesare Ruffolo; Daniele Neri; Nicolò Bassi; Antonio Giordano; Giacomo Zanus; Giuseppe A Ferraro; Umberto Cillo
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

Review 4.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

5.  Aldehyde Dehydrogenase Activity in Adipose Tissue: Isolation and Gene Expression Profile of Distinct Sub-population of Mesenchymal Stromal Cells.

Authors:  Mehdi Najar; Emerence Crompot; Leo A van Grunsven; Laurent Dollé; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

6.  The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.

Authors:  Hussein Fayyad-Kazan; Wissam H Faour; Bassam Badran; Laurence Lagneaux; Mehdi Najar
Journal:  Inflamm Res       Date:  2016-03-08       Impact factor: 4.575

7.  Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients.

Authors:  Christopher Duma; Oleg Kopyov; Alex Kopyov; Mark Berman; Elliot Lander; Michael Elam; Michael Arata; David Weiland; Ruslana Cannell; Chad Caraway; Sean Berman; Kristin Scord; Lian Stemler; Karlyssa Chung; Samuel Khoudari; Rory McRory; Chace Duma; Sawyer Farmer; Anthony Bravo; Christian Yassa; Ami Sanathara; Elisa Singh; Benjamin Rapaport
Journal:  Mol Biol Rep       Date:  2019-07-20       Impact factor: 2.316

8.  Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro.

Authors:  Jeroen van de Peppel; Gerben J Schaaf; Adriana Arruda Matos; Yuan Guo; Tanja Strini; Wenda Verschoor; Amel Dudakovic; Andre J van Wijnen; Johannes P T M van Leeuwen
Journal:  Stem Cells Dev       Date:  2021-03       Impact factor: 3.272

9.  Identification and characterisation of maternal perivascular SUSD2+ placental mesenchymal stem/stromal cells.

Authors:  Fiona L Cousins; Caroline E Gargett; Manijeh Khanmohammadi; Shayanti Mukherjee; Saeedeh Darzi; Kallyanashis Paul; Jerome A Werkmeister
Journal:  Cell Tissue Res       Date:  2021-05-07       Impact factor: 5.249

10.  Isolation of human bone marrow stromal cells from bone marrow biopsies for single-cell RNA sequencing.

Authors:  Hélène F E Gleitz; Inge A M Snoeren; Stijn N R Fuchs; Nils B Leimkühler; Rebekka K Schneider
Journal:  STAR Protoc       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.